Canada markets closed

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.93-0.62 (-7.25%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
0
0
0
500
0
Operating Expenses
Research Development
9,367
8,310
7,900
4,522
3,206
Selling General and Administrative
4,547
4,389
3,693
2,739
1,313
Total Operating Expenses
13,824
12,494
10,737
6,047
4,275
Operating Income or Loss
-13,824
-12,494
-10,737
-5,547
-4,275
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
360
229
119
-107
15
Income Before Tax
-13,464
-12,265
-10,618
-5,654
-4,260
Income Tax Expense
25
27
31
80
0
Income from Continuing Operations
-13,489
-12,292
-10,649
-5,734
-4,260
Net Income
-13,489
-12,292
-10,649
-5,734
-4,260
Net Income available to common shareholders
-13,489
-12,292
-10,649
-5,734
-4,260
Basic EPS
-
-
-0.89
-0.74
-0.72
Diluted EPS
-
-
-0.89
-0.74
-0.72
Basic Average Shares
-
-
11,988
7,744
5,936
Diluted Average Shares
-
-
11,988
7,744
5,936
EBITDA
-
-12,473
-10,716
-5,532
-4,271